Published in Blood on August 01, 1989
Refractive index maps and membrane dynamics of human red blood cells parasitized by Plasmodium falciparum. Proc Natl Acad Sci U S A (2008) 4.10
Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell (2008) 3.80
Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol (2009) 2.62
A microfluidic model for single-cell capillary obstruction by Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A (2003) 2.48
The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood (2010) 2.17
Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum. Proc Natl Acad Sci U S A (2007) 2.14
Membrane specific mapping and colocalization of malarial and host skeletal proteins in the Plasmodium falciparum infected erythrocyte by dual-color near-field scanning optical microscopy. Proc Natl Acad Sci U S A (1997) 1.58
A microfabricated deformability-based flow cytometer with application to malaria. Lab Chip (2011) 1.53
The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood (2010) 1.52
A two-compartment model of osmotic lysis in Plasmodium falciparum-infected erythrocytes. Biophys J (2003) 1.36
Yield strength of human erythrocyte membranes to impulsive stretching. Biophys J (2013) 1.33
Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta. Infect Immun (2002) 1.29
Microfluidic modeling of cell-cell interactions in malaria pathogenesis. PLoS Pathog (2007) 1.25
Quantitative imaging of human red blood cells infected with Plasmodium falciparum. Biophys J (2010) 1.18
Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum. Cell Microbiol (2012) 1.18
The homeostasis of Plasmodium falciparum-infected red blood cells. PLoS Comput Biol (2009) 1.15
Deformability limits of Plasmodium falciparum-infected red blood cells. Cell Microbiol (2009) 1.14
Antimalarial activities of dermaseptin S4 derivatives. Antimicrob Agents Chemother (2000) 1.10
Biophysics of malarial parasite exit from infected erythrocytes. PLoS One (2011) 1.08
A microfluidic device for simultaneous electrical and mechanical measurements on single cells. Biomicrofluidics (2011) 1.06
Dynamic deformability of Plasmodium falciparum-infected erythrocytes exposed to artesunate in vitro. Integr Biol (Camb) (2013) 1.02
If cell mechanics can be described by elastic modulus: study of different models and probes used in indentation experiments. Biophys J (2014) 0.99
Pf155/RESA protein influences the dynamic microcirculatory behavior of ring-stage Plasmodium falciparum infected red blood cells. Sci Rep (2012) 0.99
Febrile temperature leads to significant stiffening of Plasmodium falciparum parasitized erythrocytes. Am J Physiol Cell Physiol (2008) 0.97
How malaria parasites reduce the deformability of infected red blood cells. Biophys J (2012) 0.96
Malaria: modification of the red blood cell and consequences in the human host. Br J Haematol (2011) 0.96
Simulation of malaria-infected red blood cells in microfluidic channels: Passage and blockage. Biomicrofluidics (2013) 0.96
Life cycle-dependent cytoskeletal modifications in Plasmodium falciparum infected erythrocytes. PLoS One (2013) 0.94
Rare-cell enrichment by a rapid, label-free, ultrasonic isopycnic technique for medical diagnostics. Angew Chem Int Ed Engl (2014) 0.93
Surface area loss and increased sphericity account for the splenic entrapment of subpopulations of Plasmodium falciparum ring-infected erythrocytes. PLoS One (2013) 0.93
Plasmodium falciparum STEVOR proteins impact erythrocyte mechanical properties. Blood (2011) 0.93
Transcriptional profiling defines dynamics of parasite tissue sequestration during malaria infection. Genome Med (2015) 0.90
Measuring cell mechanics by optical alignment compression cytometry. Lab Chip (2013) 0.89
A member of the Plasmodium falciparum PHIST family binds to the erythrocyte cytoskeleton component band 4.1. Malar J (2013) 0.88
Identification of a Plasmodium falciparum phospholipid transfer protein. J Biol Chem (2013) 0.87
Cytoadherence of erythrocytes invaded by Plasmodium falciparum: quantitative contact-probing of a human malaria receptor. Acta Biomater (2013) 0.86
Viscoelasticity as a biomarker for high-throughput flow cytometry. Biophys J (2013) 0.85
Microfluidic approaches to malaria pathogenesis. Cell Microbiol (2008) 0.84
The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential? Malar J (2015) 0.83
Quantitative Biomechanics of Healthy and Diseased Human Red Blood Cells using Dielectrophoresis in a Microfluidic System. Extreme Mech Lett (2014) 0.83
Stretching and relaxation of malaria-infected red blood cells. Biophys J (2013) 0.82
Export of malaria proteins requires co-translational processing of the PEXEL motif independent of phosphatidylinositol-3-phosphate binding. Nat Commun (2016) 0.80
Is the development of falciparum malaria in the human host limited by the availability of uninfected erythrocytes? Malar J (2002) 0.80
Simple display system of mechanical properties of cells and their dispersion. PLoS One (2012) 0.79
The Cytoplasmic Region of Plasmodium falciparum SURFIN4.2 Is Required for Transport from Maurer's Clefts to the Red Blood Cell Surface. Trop Med Health (2015) 0.79
Differential time-dependent volumetric and surface area changes and delayed induction of new permeation pathways in P. falciparum-infected hemoglobinopathic erythrocytes. Cell Microbiol (2016) 0.78
Differential Spleen Remodeling Associated with Different Levels of Parasite Virulence Controls Disease Outcome in Malaria Parasite Infections. mSphere (2015) 0.76
Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy. Malar J (2015) 0.76
AFM study shows prominent physical changes in elasticity and pericellular layer in human acute leukemic cells due to inadequate cell-cell communication. Nanotechnology (2016) 0.75
Stiffening of Red Blood Cells Induced by Cytoskeleton Disorders: A Joint Theory-Experiment Study. Biophys J (2015) 0.75
Expansion of Lysine-rich Repeats in Plasmodium Proteins Generates Novel Localization Sequences That Target the Periphery of the Host Erythrocyte. J Biol Chem (2016) 0.75
Sequestration and Red Cell Deformability as Determinants of Hyperlactatemia in Falciparum Malaria. J Infect Dis (2015) 0.75
Spectrophotometric detection of susceptibility to anti-malarial drugs. Malar J (2013) 0.75
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg (2000) 5.50
Replacing the mercury sphygmomanometer. Requires clinicians to demand better automated devices. BMJ (2000) 4.30
Oxpentifylline treatment of venous ulcers of the leg. BMJ (1990) 3.75
Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? BMJ (1993) 3.69
Will the millimetre of mercury be replaced by the kilopascal? J Hypertens (1998) 3.44
A simple method for measuring erythrocyte deformability. J Clin Pathol (1976) 2.81
ABC of hypertension: Blood pressure measurement. Part II-conventional sphygmomanometry: technique of auscultatory blood pressure measurement. BMJ (2001) 2.62
Impaired red cell deformability in peripheral vascular disease. Lancet (1976) 2.40
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Dippers and non-dippers. Lancet (1988) 2.28
Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J (1973) 2.17
Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol (2003) 2.15
Progressive telomere shortening in aplastic anemia. Blood (1998) 2.10
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Leukocytes and the risk of ischemic diseases. JAMA (1987) 2.03
Drug therapy: Management of hypertension in the elderly. N Engl J Med (1980) 2.03
Blood pressure measurement: current practice and future trends. Br Med J (Clin Res Ed) (1985) 1.99
Will mercury manometers soon be obsolete? J Hum Hypertens (1995) 1.98
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Measurement of blood pressure in children. Recommendations of a working party of the British Hypertension Society. BMJ (1989) 1.95
Retinal abnormalities in diseases of the blood. Br J Ophthalmol (1969) 1.94
ABC of hypertension: The pathophysiology of hypertension. BMJ (2001) 1.90
Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The "Ad Hoc' Working Group. Hypertension (1997) 1.90
Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed) (1988) 1.85
Familial excess longevity in Utah genealogies. J Gerontol A Biol Sci Med Sci (2001) 1.84
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
ABC of hypertension: Blood pressure measurement. Part IV-automated sphygmomanometry: self blood pressure measurement. BMJ (2001) 1.77
Clinical significance of blood viscosity. Ann R Coll Surg Engl (1970) 1.75
Influence of blood viscosity on blood flow and the effect of low molecular weight dextran. Br Med J (1971) 1.72
Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet (1977) 1.67
Ambulatory blood pressure in the hypertensive population: patterns and prevalence of hypertensive subforms. J Hypertens (1998) 1.60
Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer. Angiology (2000) 1.57
Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow. Stem Cells (1994) 1.57
Inaccuracy of the Dinamap 8100 portable monitor. Lancet (1997) 1.56
Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region. Am J Hum Genet (1994) 1.52
The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood (1996) 1.52
Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol (1996) 1.51
Stress arteriography. Lancet (1973) 1.49
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens (2001) 1.49
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant (2005) 1.47
Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*. J Gen Intern Med (2001) 1.45
Aplastic anaemia and remoxipride. Lancet (1993) 1.43
Educational value of printed information for patients with hypertension. Br Med J (Clin Res Ed) (1981) 1.42
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
Long-term culture of aplastic anaemia bone marrow. Br J Haematol (1990) 1.42
Fatal aplastic anaemia after mesalazine. Lancet (1994) 1.42
Hypercoagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg (1997) 1.41
Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia. Bone Marrow Transplant (1997) 1.40
Inter-society consensus for the management of peripheral arterial disease. Int Angiol (2007) 1.39
Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J (1973) 1.39
Functional status and health service planning. J Qual Clin Pract (1999) 1.39
A review of alternative approaches in the management of iatrogenic femoral pseudoaneurysms. Ann R Coll Surg Engl (1999) 1.38
Evaluation of the accuracy and reproducibility of the Takeda TM-2420 in the elderly. J Hum Hypertens (1995) 1.38
Accuracy and performance of the terumo ES-H51, a new portable blood pressure monitor. Am J Hypertens (1994) 1.38
Relapse of severe aplastic anaemia after influenza immunization. Br J Haematol (2002) 1.37
Where are the guidelines for treating hypertension in elderly patients? BMJ (1992) 1.37
Cyclosporin A, methylprednisolone, and convulsions. Lancet (1982) 1.37
Ambulatory blood pressure measurement in general practice. Br J Gen Pract (1992) 1.36
Stability of cyclosporin A in human serum. J Clin Pathol (1983) 1.34
ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. BMJ (2001) 1.33
White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed) (1988) 1.32
Arthroscopic microdiscectomy and selective fragmentectomy. Clin Orthop Relat Res (1998) 1.32
Abnormal blood viscosity in Raynaud's phenomenon. Lancet (1976) 1.30
Haemorrheological response to plasma exchange in Raynaud's syndrome. Br Med J (1979) 1.28
Transcutaneous oxygen tension during exercise in patients with claudication. Br Med J (Clin Res Ed) (1986) 1.23
Second international consensus meeting on twenty-four-hour ambulatory blood pressure measurement: consensus and conclusions. J Hypertens Suppl (1991) 1.23
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23
Report on variation in rates of utilization of surgical services in the Commonwealth of Massachusetts. JAMA (1985) 1.22
Transforaminal arthroscopic decompression of lateral recess stenosis. J Neurosurg (1996) 1.20
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood (1991) 1.18
Selective sparing of enterochromaffin cells in graft versus host disease affecting the colonic mucosa. Histopathology (1985) 1.18
Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant (1986) 1.17
Pacing on demand in the treatment of atrioventricular conduction-disturbances of the heart. Lancet (1966) 1.17
Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg. Br Med J (Clin Res Ed) (1988) 1.17
Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. Int Angiol (1999) 1.16
Reliability of ankle:brachial pressure index measurement by junior doctors. Br J Surg (1994) 1.15
Fanconi anaemia--constitutional, familial aplastic anaemia. Baillieres Clin Haematol (1989) 1.14
Profile of persons with disabilities in Medicare and Medicaid. Health Care Financ Rev (1996) 1.14
Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol (1999) 1.13
Accelerated thrombolysis using pulsed intra-thrombus recombinant human tissue type plasminogen activator (rt-PA). Eur J Vasc Surg (1992) 1.13
Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet (1979) 1.12
Preoperative haemoglobin as predictor of outcome of diabetic amputations. Lancet (1979) 1.12
The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol (2001) 1.11
Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol (2001) 1.11
Chronic T cell lymphocytosis: a review of 21 cases. Br J Haematol (1984) 1.10
Screening donor blood for malaria by polymerase chain reaction. Trans R Soc Trop Med Hyg (1995) 1.09
Pregnancy associated aplastic anaemia: a report of five cases and review of current management. Br J Haematol (1989) 1.08
Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet (1982) 1.08
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood (1992) 1.07
Strike and the medical profession. Ir Med J (1987) 1.07
Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Br J Haematol (1983) 1.07
Clinical outcome and restenosis following percutaneous transluminal angioplasty for ischaemic rest pain or ulceration. Br J Surg (1995) 1.06
Peroperative t-PA thrombolysis. Lancet (1991) 1.05
4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res (1985) 1.04
Adverse effects of human leukocyte antigen-DR sharing on fertility: a cohort study in a human isolate. Fertil Steril (1985) 1.04